ASEM documentary overview
Official National Advisory Committee on Immunization document (2020) on “Archived: Interim Statement on the Use of the rVSVΔG-ZEBOV-GP Vaccine for the Prevention of Ebola Virus Disease”. Merck’s investigational rVSVΔG-ZEBOV-GP vaccine is a live-attenuated, recombinant vesicular stomatitis virus (rVSV)-based vector vaccine against Zaire ebolavirus (ZEBOV).
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document